Low-dose computed tomography

Low-dose computed tomography has been studied in 56 papers since 2022: 5 trials and 27 observational studies in people, 22 reviews; 51 in the past year. The newest story, Oct 27, 2026: “Lower bone density on lung scans linked to spine fractures”.

Intervention

56 papers study it20 findingsUpdated

3 new papers in 30 daysSee all 56 papers on low-dose computed tomography

At a glance

A human trial links positive baseline low-dose CT to higher lung cancer incidence and all-cause and lung cancer mortality. Reviews describe earlier lung cancer detection and lower lung cancer mortality in humans; a review preprint describes cardiovascular risk prediction during lung cancer screening.

20 findings in 17 papers from 2022 to 2026, 10 of them since July 2026

Independent labs found the same change in people. 6 independent labs in 6 countries.

“with significantly higher incidence in the LDCT + group (21.8 % vs 3.0 %, p < 0.0001)”
Long-term efficacy and adherence of a lung cancer screening strategy with extended LDCT intervals: Results from the BioMILD trialLung cancer (Amsterdam, Netherlands)2026doi:10.1016/j.lungcan.2026.109629

1 of its findings points the other way.

Humans: replicated by independent labs. Cells, worms or flies and mice: nothing yet.
  • 6 independent labs in 6 countries
  • 1 finding against
  • Funders: National Cancer Institute and others
  • 2 of 7 findings with company ties
  • Human trial5
  • Humans27
  • In silico2

What did studies of low-dose computed tomography find?

5

Studies of low-dose computed tomography measured 5 outcomes; the most studied are mortality (6 studies) and lung cancer mortality (5).

Mortality

downin humans6−6.7%

6 studies
  1. Low-dose computed tomography decreases mortality in humans.

    “Low-dose CT lung cancer screening reduces lung cancer mortality in individuals at high risk”

    Review

    Lung Cancer Screening: Beyond Pulmonary Nodules

    Radiographics : a review publication of the Radiological Society of North America, Inc

  2. Low-dose computed tomography decreases mortality in humans (versus chest radiography) (-6.7%).

    “6.7% reduction in all-cause mortality with LDCT versus chest radiography”

    Reviewversus chest radiography

    Sixty Years of Lung Cancer Screening: From Sputum Cytology to Low-Dose CT and the Emerging Precision Era

    Academic radiology

  3. Low-dose computed tomography decreases mortality in humans (high-risk individuals).

    “Low-dose computed tomography (LDCT) to screen high-risk individuals has proven effective in the reduction of lung-cancer (LC) specific mortality.”

    Reviewhigh-risk individuals

    Experience of the implementation of a lung cancer screening program at the Hospital General de Catalunya (Barcelona, Spain)

    Current problems in cancer

  4. Low-dose computed tomography decreases mortality in lung cancer screening.

    “Low-dose computed tomography lung cancer screening (LDCT-LCS) significantly reduces mortality”

    Reviewin lung cancer screening

    Use and impact of risk-based eligibility models in low-dose computed tomography lung cancer screening: a systematic review

    Public health reviews

  5. Low-dose computed tomography decreases mortality in humans.

    “low-dose computed tomography (LDCT) screening reduces lung cancer mortality”

    Review

    Scaling AI-enabled imaging-based screening: lessons from reporting for the NHS England lung cancer screening programme

    Clinical radiology

  6. Low-dose computed tomography decreases mortality in high-risk populations (>20%).

    “Landmark trials, including NLST and NELSON, demonstrated mortality reductions exceeding 20%, establishing LDCT as the standard of care for early detection in high-risk populations.”

    Reviewin high-risk populations

    A Game-Changing 20 Years: Progress and Future Directions in Lung Cancer Screening

    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Lung cancer mortality

downin humans5−20%

5 studies
  1. Low-dose computed tomography decreases lung cancer mortality in humans.

    “screening using low-dose computed tomography reduces lung cancer mortality”

    Review

    Implementation of a national lung cancer screening in Austria : Position paper of the Austrian Radiological Society (ÖRG), the Austrian Society of Pneumology (ÖGP), the Austrian Society of General Practice and Family Medicine (ÖGAM) and the Austrian Society of Thoracic Surgery (ÖGTC)

    Wiener klinische Wochenschrift

  2. Low-dose computed tomography decreases lung cancer mortality in humans (versus chest radiography) (-20%).

    “The NLST demonstrated a 20% reduction in lung cancer mortality and 6.7% reduction in all-cause mortality with LDCT versus chest radiography”

    Reviewversus chest radiography

    Sixty Years of Lung Cancer Screening: From Sputum Cytology to Low-Dose CT and the Emerging Precision Era

    Academic radiology

  3. Low-dose computed tomography decreases lung cancer mortality in humans (screening).

    “the only validated screening intervention proven to reduce lung cancer mortality.”

    Reviewscreening

    Reframing computed tomography-associated cancer concerns in lifesaving screening: keeping the focus on lives saved

    Lancet regional health. Americas

  4. Low-dose computed tomography decreases lung cancer mortality in high-risk populations defined by age and smoking history.

    “Low-dose computed tomography (LDCT)-based screening reduces lung cancer mortality in high-risk populations defined by age and smoking history”

    Reviewin high-risk populations defined by age and smoking history

    Innovative approaches for lung cancer screening and interception

    Nature reviews. Clinical oncology

  5. Low-dose computed tomography decreases lung cancer mortality in humans.

    “Lung cancer screening with low-dose computed tomography reduces lung cancer mortality in the long term but carries immediate risks.”

    Review7.3 to 12.3 yearsn = 88,526

    Time to Benefit for Lung Cancer Screening: A Systematic Review and Survival Meta-Analysis

    American journal of preventive medicine

Early-stage lung cancer detection

upin humans1

1 study
  1. Low-dose computed tomography increases early-stage lung cancer detection in humans.

    “increases the detection of early-stage, potentially curable disease”

    Review

    Implementation of a national lung cancer screening in Austria : Position paper of the Austrian Radiological Society (ÖRG), the Austrian Society of Pneumology (ÖGP), the Austrian Society of General Practice and Family Medicine (ÖGAM) and the Austrian Society of Thoracic Surgery (ÖGTC)

    Wiener klinische Wochenschrift

Early detection

upin humans1

1 study
  1. Low-dose computed tomography increases early detection in occupational settings.

    “Screening enables early detection and reduces mortality.”

    Reviewin occupational settings

    Lung cancer screening in occupational settings: a scoping review

    Frontiers in public health

Early-stage lung cancer proportion

upin humans1

1 study
  1. Low-dose computed tomography is linked with higher early-stage lung cancer proportion in humans (ever-smokers meeting risk thresholds).

    “This has increased the early-stage proportion of lung cancer in England over 5 years, particularly in socioeconomically deprived regions.”

    Humansever-smokers meeting risk thresholdsthorax5 years

    Implementation of the NHS England Lung Cancer Screening Programme over 5 years

    Nature medicine

What is low-dose computed tomography linked with?

5

Studies link low-dose computed tomography with 5 measures, among them lung cancer, preventive management and mortality.

Lung cancer

upin humans2+5.5%

2 studies
  1. Low-dose computed tomography predicts lung cancer in humans (stratified by baseline LDCT results into LDCT + vs LDCT -) (21.8 % vs 3.0 %).

    “with significantly higher incidence in the LDCT + group (21.8 % vs 3.0 %, p < 0.0001)”

    Human trialstratified by baseline LDCT results into LDCT + vs LDCT -median follow-up of 9.4 yearsn = 4,119

    Long-term efficacy and adherence of a lung cancer screening strategy with extended LDCT intervals: Results from the BioMILD trial

    Lung cancer (Amsterdam, Netherlands)

  2. Low-dose computed tomography is associated with lung cancer in humans (5.5%).

    “The detection rate of positive nodules and of lung cancer was 78.4% and 5.5%, respectively.”

    Humans10-year follow-up

    Analysis of pulmonary nodules detected by annual low-dose computed tomography in the elderly during a 10-year follow-up

    Geriatrics & gerontology international

More on Lung cancer

Preventive management

upin humans1

1 study
  1. Low-dose computed tomography is associated with preventive management in humans (screening-eligible individuals).

    “observational data indicate that reporting these markers changes preventive management, but whether this improves cardiovascular outcomes has not yet been demonstrated.”

    Reviewscreening-eligible individuals

    Opportunistic Cardiovascular Assessment During Lung Cancer Screening with Low-Dose Computed Tomography: A New Window for Prevention

    Advances in respiratory medicine

Mortality

upin humans1

1 study
  1. Low-dose computed tomography predicts mortality in humans (LDCT + vs LDCT -) (14 % vs 6 % all-cause, 5 % vs 1 % LC).

    “Ten-year all-cause and LC mortality were significantly higher in the LDCT + group (14 % and 5 %) compared to the LDCT - group (6 % and 1 %) (p < 0.0001).”

    Human trialLDCT + vs LDCT -10-yearn = 4,119

    Long-term efficacy and adherence of a lung cancer screening strategy with extended LDCT intervals: Results from the BioMILD trial

    Lung cancer (Amsterdam, Netherlands)

Cardiovascular risk

upin humans1

1 study
  1. Low-dose computed tomography predicts cardiovascular risk in humans (lung cancer screening).

    “Screening LDCT can provide robust risk-informative markers and pragmatic visual grading”

    Reviewlung cancer screening

    Opportunistic Cardiovascular Assessment During Lung Cancer Screening with Low-Dose Computed Tomography: A New Window for Prevention

    Preprints.orgPreprint

Cancer

upin silico1

1 study
  1. Low-dose computed tomography raises the risk of cancer in silico (16 per 100,000 screened women).

    “We estimated a lifetime attributable risk of 16 radiation-induced cancers per 100,000 screened women (7 in men, respectively)”

    In silicofemales

    Lung cancer screening by low-dose computed tomography: A modelling study to evaluate radiation-induced cancer risks, and the influence of smoking behavior

    Cancer epidemiology

More on Cancer

Funding

5 grants since 2016

National Cancer Institute$7.3MJapan Society for the Promotion of Science¥4.6MNational Health and Medical Research CouncilA$3M

How this record changed

  1. Summary written from the findings.

Latest

Dec 2025: 1Jan 2026: 8Feb 2026: 6Mar 2026: 8Apr 2026: 0May 2026: 2Jun 2026: 1Jul 2026: 3Aug 2026: 6Sep 2026: 8Oct 2026: 8Nov 2026: 051 papers in 12 months
Radiology

Lower bone density on lung scans linked to spine fractures

Over two years, spine fractures occurred in 0.9% of participants with normal bone mass, 2.0% with low bone mass and 5.9% with osteoporosis.Over two years, spine fractures occurred in 0.9% of participants with normal bone mass, 2.0% with low bone mass and 5.9% with osteoporosis.

Cohort · 18,211 peopleVertebral fracture

See all 56 papers on low-dose computed tomography